Table 3 Independent risk factors for persistent SARS-CoV-2 infection in NHL patients
Risk Factor | Persistent SARS-CoV-2 Group (n = 110) | Non-persistent SARS-CoV-2 Group (n = 550) | Adjusted OR (95% CI) | Adjusted p-value |
|---|---|---|---|---|
Hypertension (n, %) | 71 (64.5%) | 192 (34.9%) | 2.21 (1.61–3.03) | < 0.001 |
Immunosuppressive Status (n, %) | 76 (69.1%) | 76 (13.8%) | 5.72 (3.89–8.41) | < 0.001 |
Lymphocyte Count (×109/L, mean ± SD) | 0.7 ± 0.4 | 1.2 ± 0.6 | 0.45 (0.32–0.63) | < 0.001 |
Lung Lesions (n, %) | 95 (86.4%) | 160 (29.1%) | 5.29 (3.86–7.25) | < 0.001 |